AGM and Dividend Timetable

London, 20 May 2015: NMC Health Plc ("NMC" or the "Company") (LSE:NMC), the leading integrated private healthcare provider operating across the United Arab Emirates, and one of the top global providers of fertility treatment through its Spanish subsidiary Clinica Eugin, announces circulation of its Notice of 2015 Annual General Meeting and confirms details of the timetable for payment of its 2014 final dividend.

The Company's 2015 Annual General Meeting will be held on Tuesday 16 June 2015, at 2:00 pm at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD. The Notice of Meeting for the 2015 Annual General Meeting and the associated Form of Proxy have today been published and posted to shareholders. Both documents can be viewed online at www.nmchealth.com.

Following the 2014 financial year preliminary results announcement of the Company made on 24 February 2015, in which the Board announced that it is recommending a final dividend of 5.4 pence per ordinary share, the Company hereby confirms the following timetable for payment of this dividend:

· Ex-dividend date - 28 May 2015

· Record date - 29 May 2015

· Payment date - 25 June 2015

Payment of the final dividend remains subject to shareholder approval at the Company's 2015 Annual General Meeting.

Contacts

Investors

NMC

Simon Watkins, Group Company Secretary +44 (0)20 3102 9460

Media:

FTI Consulting, London

Matthew Cole +44 (0)20 3727 1101

 FTI Consulting, Gulf

Shane Dolan +971 (0)4 437 2100

About NMC

NMC Health plc group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Healthcare Division currently operates or manages seven hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. The enlarged company received almost 2.8m patients in 2014.The group also operates a significant UAE wide Distribution business supplying product lines across several key market segments, including: Pharmaceutical, FMCG, Food and Scientific and Medical Equipment. NMC Health plc group reported revenues of US$ 644m in 2014.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. At the time of its IPO, the group raised funds to enable it to pursue a further growth plan with a number of capital projects for new healthcare facilities in Abu Dhabi and Dubai. NMC Health plc is a constituent of the FTSE 250 Index.